CUREVAC N V's ticker is CVAC and the CUSIP is N2451R105. A total of 91 filers reported holding CUREVAC N V in Q2 2022. The put-call ratio across all filers is 1.26 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $11,105,191 | -34.5% | 1,625,943 | 0.0% | 13.24% | -1.8% |
| Q2 2023 | $16,942,326 | +49.5% | 1,625,943 | 0.0% | 13.48% | +34.8% |
| Q1 2023 | $11,332,823 | +15.6% | 1,625,943 | 0.0% | 10.01% | +32.5% |
| Q4 2022 | $9,804,436 | -27.4% | 1,625,943 | -4.9% | 7.56% | -29.2% |
| Q3 2022 | $13,500,000 | -42.1% | 1,709,781 | 0.0% | 10.67% | -40.4% |
| Q2 2022 | $23,300,000 | -30.4% | 1,709,781 | 0.0% | 17.91% | -0.6% |
| Q1 2022 | $33,500,000 | -68.9% | 1,709,781 | -45.5% | 18.01% | -44.8% |
| Q4 2021 | $107,600,000 | -37.1% | 3,134,780 | 0.0% | 32.65% | -34.9% |
| Q3 2021 | $171,200,000 | -25.6% | 3,134,780 | 0.0% | 50.12% | +41.8% |
| Q2 2021 | $230,000,000 | -19.8% | 3,134,780 | 0.0% | 35.34% | -24.7% |
| Q1 2021 | $286,707,000 | +12.9% | 3,134,780 | 0.0% | 46.92% | -19.1% |
| Q4 2020 | $254,000,000 | – | 3,134,780 | – | 58.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bill & Melinda Gates Foundation | 1,709,781 | $23,300,000 | 17.91% |
| Pinz Capital Management, LP | 40,200 | $547,000 | 0.38% |
| Parametrica Management Ltd | 13,513 | $184,000 | 0.20% |
| MQS Management LLC | 16,176 | $220,000 | 0.15% |
| Quantamental Technologies LLC | 11,552 | $157,000 | 0.07% |
| Ergoteles LLC | 98,100 | $1,335,000 | 0.04% |
| Virtus ETF Advisers LLC | 7,676 | $104,000 | 0.04% |
| Green Alpha Advisors, LLC | 12,247 | $167,000 | 0.04% |
| ETF MANAGERS GROUP, LLC | 53,789 | $746,000 | 0.02% |
| Quantbot Technologies LP | 14,800 | $201,000 | 0.02% |